Price development of orphan drugs in Germany after market access and subsequent assessments: a descriptive analysis
- DOI
- 10.1007/s10198-026-01926-3
- Published
- 2026-04-22
- Container
- The European Journal of Health Economics
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10198-026-01926-3,
title = {Price development of orphan drugs in Germany after market access and subsequent assessments: a descriptive analysis},
author = {C. Balg and K. Frangen and A. C. Brockhaus and S. Sturtz and A. Schwalm and S. Mostardt},
year = {2026},
journal = {The European Journal of Health Economics},
doi = {10.1007/s10198-026-01926-3},
url = {https://doi.org/10.1007/s10198-026-01926-3}
}RIS
TY - JOUR TI - Price development of orphan drugs in Germany after market access and subsequent assessments: a descriptive analysis AU - C. Balg AU - K. Frangen AU - A. C. Brockhaus AU - S. Sturtz AU - A. Schwalm AU - S. Mostardt PY - 2026 JO - The European Journal of Health Economics DO - 10.1007/s10198-026-01926-3 UR - https://doi.org/10.1007/s10198-026-01926-3 ER -
APA
Balg, C., Frangen, K., Brockhaus, A. C., Sturtz, S., Schwalm, A., & Mostardt, S. (2026). Price development of orphan drugs in Germany after market access and subsequent assessments: a descriptive analysis. The European Journal of Health Economics. https://doi.org/10.1007/s10198-026-01926-3
Source records
- crossref · retrieved 2026-09-25T19:06:51.547Z